Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copper Chelation in Hypertrophic Cardiomyopathy: Trientine Pilot Study
2014-001577-13Phase 4Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of trientine in hypertrophic cardiomyopathy (HCM), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Change in myocardial energetics by cardiac MRI. Started Jun 2014; status: completed.
02
Drugs
trientine
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on 2014-001577-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001577-13.